ProEncia Biotechnology
PrivateLast Round
Pre Seed
May 19, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ProEncia Biotechnology is a biotechnology company developing a new generation of non-invasive oral care options for adult patients at all stages of periodontal disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ProEncia Biotechnology Comparables
Compare ProEncia Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PerioTrap Pharmaceuticals GmbH | 79% | |
| Nordicus Partners Corporation | 79% | |
| Oral Biolife Inc. | 78% | |
ProEncia Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 19, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Completed a Pre Seed funding round.
ProEncia Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ProEncia Biotechnology's valuation, stock price, and market status.